← Back to Search

Motivational therapy for Depression (Aftercare Trial)

N/A
Waitlist Available
Led By Suzette Glasner, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly and at follow up, up to 6 months
Awards & highlights

Aftercare Trial Summary

This trial is testing if cognitive behavioral therapy combined with motivational therapy (CBT-MT) is better than treatment as usual (TAU) in improving depression, substance use, and healthcare outcomes in a population with drug dependence and comorbid major depressive disorder (MDD).

Eligible Conditions
  • Depression
  • Substance Addiction

Aftercare Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly and at follow up, up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and weekly and at follow up, up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Depression symptoms
Change in Healthcare utilization
Change in Substance Use
Secondary outcome measures
Cognitive functioning
Efficacy and outcomes of CBT-MT and TAU
HIV-risk behavior of participants

Aftercare Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Motivational Therapy AftercareExperimental Treatment1 Intervention
Twelve, 60 minute weekly structured manualized therapy sessions.
Group II: Dual Recovery Anonymous/Tx as usualActive Control1 Intervention
Aftercare Treatment as Usual,which is twelve 60 minute weekly sessions of peer led 12-step Dual Recovery Anonymous group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Motivational therapy
2008
N/A
~140

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,276,815 Total Patients Enrolled
101 Trials studying Depression
48,407 Patients Enrolled for Depression
National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,557 Total Patients Enrolled
38 Trials studying Depression
62,557 Patients Enrolled for Depression
Suzette Glasner, PhDPrincipal InvestigatorUniversity of California, Los Angeles
4 Previous Clinical Trials
336 Total Patients Enrolled
1 Trials studying Depression
39 Patients Enrolled for Depression

Media Library

Dual Recovery Anonymous/Treatment as usual Clinical Trial Eligibility Overview. Trial Name: NCT01189799 — N/A
Depression Research Study Groups: Motivational Therapy Aftercare, Dual Recovery Anonymous/Tx as usual
Depression Clinical Trial 2023: Dual Recovery Anonymous/Treatment as usual Highlights & Side Effects. Trial Name: NCT01189799 — N/A
Dual Recovery Anonymous/Treatment as usual 2023 Treatment Timeline for Medical Study. Trial Name: NCT01189799 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Motivational Therapy for Substance Users With Depression
Suzette Glasner-Edwards 2007. "Motivational Therapy for Substance Users With Depression". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01189799.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top